Omid Hamid
MD
Chief of Translational Research, The Angeles Clinic
👥Biography 个人简介
Omid Hamid has been instrumental in developing tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma, including participation in pivotal trials of lifileucel. He is also an experienced investigator of checkpoint inhibitor combinations and novel immunotherapy constructs for melanoma. His work on adoptive cell therapy, particularly in patients who have progressed on multiple lines of IO, offers new options for refractory melanoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Omid Hamid 的研究动态
Follow Omid Hamid's research updates
留下邮箱，当我们发布与 Omid Hamid（Cedars-Sinai Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment